The medical technology's currency is clinical route

Clinical pathways are a recognized set of rules for the delivery of treatment, and their importance is growing as healthcare becomes more and more ingrained in the digital revolution.

                                                         image source:techcrunch

Clinical pathways are the "standardization of care that translates recommendations and/or evidence into localized infrastructure and processes," according to the Children's Hospital of Philadelphia. These procedures can reduce payer (insurance) denials, enable providers to participate in performance-based reimbursement, or assist provider systems with limited financial resources in effectively allocating resources.

These financial advantages have paved the way for pathways to become the de facto operating system for healthcare, along with current macroeconomic forces such as the fight for profitability in hospital systems, the rise of team-based care (provided by non-physicians), the difficulties of utilization management at scale for insurance companies, and strict legislation around patient communication and healthcare systems interoperability requirements.

Pathways offer a means of exchange for patients, clinicians, payers, and IT firms to demonstratea clinical and financial return on investment (ROI). In the end, this has created a special opportunity for both new and established healthcare companies to develop pathways, utilizing new datasets, offering novel reimbursement models, preparing for and complying with new transparency and interoperability legislation, and utilizing advanced AI to provide individualized understanding and delivery of information.

The success of the pathway in clinical and operational contexts is driven by data

In the past, local decisions had to be made in accordance with national regulations. Thanks to the ability to acquire, produce, and evaluate new datasets, decisions are now being driven by local, even personalized, evidence-based paths.

Datavant is one example of a HIPAA-compliant collaboration tool that will help you establish a more democratized, fine-tuned system of analysis for individualized paths. Access to data, standardization of data rights, and use of these tools will all help you stay in compliance. Under the guidance of numerous healthcare organizations, the Centers for Medicare & Medicaid Services (CMS) is currently establishing an authorized format for hospital charges as single machine readable files (MRFs), which will be used to standardize all charge information.Large (national) and small (local) providers will be able to access data that was previously inaccessible, which can then be used to improve care coordination and delivery, foster quality improvement, advance research, and boost ROI.

We discussed the potential for using new data models in the shift from the national to the local level for clinical logic formulation with Eric Leroux and Dan Imler, emergency department MDs and the co-founders of Curbside, a clinical pathways business. Even though nationalized datasets can aid in the generation of insights, "the clinical and financial responsibility of point-of-care decision making is still inherently local... decisions must be governed there to have any real impact," especially in value-based care constructs, they noted.We anticipate more investment in startups that concentrate on the intersection of digital health and fintech as evidence-based pathways and regionalized reimbursement engines become more important. This is because more businesses like Curbside and AvoMD work to bridge the gap between art (no guidelines) and science (NCCN guidelines) when creating pathways.

Models of reimbursement

The development of pathways has made them a "cornerstone of future reimbursement methodologies and quality efforts," as Dr. Robin Zon stated in ASCO Connection. They can assist with capturing "stage and molecular data for a more refined risk adjustment" and assisting doctors to avoid "time-consuming prior authorization and appeals with payers." Clinical pathways can now be reimbursed using a variety of models, including legacy fee-for-service (FFS) and value-based care (VBC).

To develop a baseline for cost and quality under the Medicare Shared Savings Program (MSSP), for instance, CMS employs clinical pathways. Shared savings are available to providers who can treat patients for less than the benchmark price while maintaining a particular level of quality.

content source:https://techcrunch.com/2023/07/27/clinical-pathways-are-the-currency-of-health-tech/